Benzene-initiated oxidative stress: Effects on embryonic signaling pathways

Chemico-Biological Interactions

Volumn 184, Issue 1-2, 2010, Pages 218-221

  Badham, Helen J ^a   Renaud, Stephen J ^a   Wan, Joanne ^a   Winn, Louise M ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Benzene; Developmental toxicity; Embryonic signaling pathways; In utero Carcinogen; Reactive oxygen species

Indexed keywords

ACETOACETIC ACID; BENZENE; DICHLOROFLUORESCEIN DIACETATE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C MYB; PROTEIN KINASE B; PROTEIN KINASE PIM 1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD TOXICITY; CHEMICAL CARCINOGENESIS; EMBRYO DEVELOPMENT; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; LEUKEMOGENESIS; MYELOID LEUKEMIA; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRENATAL EXPOSURE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BENZENE; CARCINOGENS; EMBRYO, MAMMALIAN; FEMALE; FETUS; MALE; MICE; NF-KAPPA B; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MYB; PROTO-ONCOGENE PROTEINS C-PIM-1; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 77950629855     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.11.005     Document Type: Article

References (36)

1. Wan J., Winn L.M. In utero-initiated cancer: the role of reactive oxygen species. Birth Defects Res. C: Embryo Today 2006, 78(4):326-332.
2. van Steensel-Moll H.A., Valkenburg H.A., van Zanen G.E. Childhood leukemia and parental occupation. A register-based case-control study. Am. J. Epidemiol. 1985, 121(2):216-224.
3. Shu X.O., Gao Y.T., Brinton L.A., Linet M.S., Tu J.T., Zheng W., Fraumeni J.F. A population-based case-control study of childhood leukemia in Shanghai. Cancer 1988, 62(3):635-644.
4. Buckley J.D., Robison L.L., Swotinsky R., Garabrant D.H., LeBeau M., Manchester P., Nesbit M.E., Odom L., Peters J.M., Woods W.G., et al. Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group. Cancer Res. 1989, 49(14):4030-4037.
5. McKinney P.A., Alexander F.E., Cartwright R.A., Parker L. Parental occupations of children with leukaemia in west Cumbria, north Humberside, and Gateshead. BMJ 1991, 302(6778):681-687.
6. Kishi R, Katakura Y., Yuasa J., Miyake H. Association of parents' occupational exposure to cancer in children. A case-control study of acute lymphoblastic leukemia. Sangyo Igaku 1993, 35(6):515-529.
7. Ning H., Kado N.Y., Kuzmicky P.A., Hsieh D.P. Benzene-induced micronuclei formation in mouse fetal liver blood, peripheral blood, and maternal bone marrow cells. Environ. Mol. Mutagen. 1991, 18(1):1-5.
8. Ciranni R, Barale R., Marrazzini A., Loprieno N. Benzene and the genotoxicity of its metabolites. I. Transplacental activity in mouse fetuses and in their dams. Mutat. Res. 1988, 208(1):61-67.
9. Lau A., Belanger C.L., Winn L.M. In utero and acute exposure to benzene: investigation of DNA double-strand breaks and DNA recombination in mice. Mutat. Res. 2009, 676(1-2):74-82.
10. Keller K.A., Snyder C.A. Mice exposed in utero to low concentrations of benzene exhibit enduring changes in their colony forming hematopoietic cells. Toxicology 1986, 42(2-3):171-181.
11. H. Badham, L. Winn, In utero exposure to benzene disrupts fetal hematopoietic progenitor cell growth via reactive oxygen species, Toxicol. Sci., in press.
12. Synder R. Benzene and leukemia. Crit. Rev. Toxicol. 2002, 32(3):155-210.
13. Kolachana P., Subrahmanyam V.V., Meyer K.B., Zhang L., Smith M.T. Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res. 1993, 53(5):1023-1026.
14. Ho T.Y., Witz G. Increased gene expression in human promyeloid leukemia cells exposed to trans, trans-muconaldehyde, a hematotoxic benzene metabolite. Carcinogenesis 1997, 18(4):739-744.
15. Wiemels J, Smith M.T. Enhancement of myeloid cell growth by benzene metabolites via the production of active oxygen species. Free Radic. Res. 1999, 30(2):93-103.
16. Winn L.M. Homologous recombination initiated by benzene metabolites: a potential role of oxidative stress. Toxicol. Sci. 2003, 72(1):143-149.
17. Wan J., Winn L.M. In utero exposure to benzene increases embryonic c-Myb and Pim-1 protein levels in CD-1 mice. Toxicol. Appl. Pharmacol. 2008, 228(3):326-333.
18. Ness S.A. Myb binding proteins: regulators and cohorts in transformation. Oncogene 1999, 18(19):3039-3046.
19. Mucenski M.L., McLain K., Kier A.B., Swerdlow S.H., Schreiner C.M., Miller T.A., Pietryga D.W., Scott W.J., Potter S.S. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991, 65(4):677-689.
20. Amson R., Sigaux F., Przedborski S., Flandrin G., Givol D., Telerman A. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc. Natl. Acad. Sci. U.S.A. 1989, 86(22):8857-8861.
21. Zhu N., Ramirez L.M., Lee R.L., Magnuson N.S., Bishop G.A., Gold M.R. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway. J. Immunol. 2002, 168(2):744-754.
22. Zemskova M., Sahakian E., Bashkirova S., Lilly M. The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells. J. Biol. Chem. 2008, 283(30):20635-20644.
23. Guzman M.L., Neering S.J., Upchurch D., Grimes B., Howard D.S., Rizzieri D.A., Luger S.M., Jordan C.T. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001, 98(8):2301-2307.
24. Cilloni D., Martinelli G., Messa F., Baccarani M., Saglio G. Nuclear factor kB as a target for new drug development in myeloid malignancies. Haematologica 2007, 92(9):1224-1229.
25. Dolcet X., Llobet D., Pallares J., Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Arch. 2005, 446(5):475-482.
26. Garg A., Aggarwal B.B. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 2002, 16(6):1053-1068.
27. Rothwarf D.M., Karin M. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci. STKE 1999, 1999(5):RE1.
28. Kucharczak J., Simmons M.J., Fan Y., Gelinas C. To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003, 22(56):8961-8982.
29. Badham H.J, Winn L.M. The production of hydroquinone in fetal liver is associated with an increased incidence of liver tumors in mice after in utero exposure to benzene. Proceedings Benzene 2009.
30. Driscoll K.E., Synder C.A. The effects of ethanol ingestion and repeated benzene exposures on benzene pharmacokinetics. Toxicol. Appl. Pharmacol. 1984, 73(3):525-532.
31. Nagata Y., Moriguchi T., Nishida E., Todokoro K. Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3. Blood 1997, 90(3):929-934.
32. Okuda K., Sanghera J.S., Pelech S.L., Kanakura Y., Hallek M., Griffin J.D., Druker B.J. Granulocyte-macrophage colony-stimulating factor, interleukin-3, and steel factor induce rapid tyrosine phosphorylation of p42 and p44 MAP kinase. Blood 1992, 79(11):2880-2887.
33. Foltz I.N, Lee J.C., Young P.R., Schrader J.W. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 1997, 272(6):3296-3301.
34. Liu R.Y., Fan C., Liu G., Olashaw N.E., Zuckerman K.S. Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-alpha-supported proliferation of leukemia and lymphoma cell lines. J. Biol. Chem. 2000, 275(28):21086-21093.
35. Hideshima T., Akiyama M., Hayashi T., Richardson P., Schlossman R., Chauhan D., Anderson K.C. Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu. Blood 2003, 101(2):703-705.
36. Ryan S., McNicholas W.T., Taylor C.T. A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation. Biochem. Biophys. Res. Commun. 2007, 355(3):728-733.